Navigation Links
Nektar Consolidates Research at Its State-of-the-Art R&D Center Located in San Francisco at Mission Bay
Date:3/20/2012

SAN FRANCISCO, March 20, 2012 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that the company is consolidating its U.S.-based research scientists at the company's existing San Francisco state-of-the-art R&D center, which is located adjacent to the UCSF research and medical campus in Mission Bay.  With the consolidation, research scientists from Nektar's Huntsville, Alabama research site will be relocating to San Francisco.  Nektar's San Francisco R&D Center at Mission Bay opened in November 2010 and includes 102,000 square feet of biology and chemistry lab space, as well as Nektar's corporate headquarters.  Under a ten-year sub-lease with Pfizer which was signed in March 2010, Nektar received free rent through July of 2014 for the newly constructed biopharmaceutical lab space.  

"Bringing our highly productive U.S. research team together in San Francisco will greatly increase our efficiency and further enhance critical interaction between research, clinical, and product strategy teams as we continue to generate new drug candidates," said Howard W. Robin, President and Chief Executive Officer of Nektar Therapeutics.  "Nektar's R&D Center in Mission Bay is located in the heart of a growing hub of leading biopharmaceutical companies and surrounded by world-renowned scientific research institutes and medical facilities." 

Nektar will continue to operate its 105,000-square-foot manufacturing and process development facility in Huntsville, Alabama that manufactures proprietary PEGylation compounds for its own clinical pipeline, as well as Nektar's pharmaceutical partners.  The facility supplies polymers for UCB's Cimzia®, Roche's PEGASYS®, Pfizer's SOMAVERT®, Amgen's NEULASTA® and Affymax's peginesatide, among others. 

The consolidation plans announced today will result
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
9. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
10. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
11. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... HILL, Conn. , July 29, 2014 Numotion,s ... 2014, Mike Swinford will be the company,s new ... a highly successful 22-year career at GE where he worked ... million in annual revenue to over $5 billion. His most ... Global Services. "I am thrilled to join ...
(Date:7/29/2014)... Fla. , July 29, 2014 /PRNewswire-iReach/ -- ... service provider, has launched its Medical Equipment ...  These services are tailored to the cruise ... standards prompted industry operators to propose that they ... MHG Medical,s new program is intended to create ...
(Date:7/29/2014)... 29, 2014  Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Chemistry (AACC) 2014 Clinical Lab Expo today by unveiling ... ways Roche is partnering with customers to redefine the ... us every day that they,re looking for a partner ... their labs and offices," said Jack Phillips , ...
Breaking Medicine Technology:Numotion Names Mike Swinford CEO 2MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4
... Schering-Plough Corporation,(NYSE: SGP ) today reported that ... Phase II study of boceprevir, its investigational oral ... chronic,hepatitis C virus (HCV) genotype 1 were presented ... for the Study of the Liver (EASL). The,ongoing ...
... Into New Promising Drugs to Combat Hepatitis ... C ... Stem Cells of Potential Benefit in Liver Transplantation, ... At today,s sessions of the 43rd Annual Meeting of the European,Association for the ...
Cached Medicine Technology:Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 3Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 4Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 5Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 6Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 7Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 8Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 9Basic Science Discoveries Yield Progress in Hepatology 2Basic Science Discoveries Yield Progress in Hepatology 3Basic Science Discoveries Yield Progress in Hepatology 4
(Date:7/29/2014)... TUESDAY, July 29, 2014 (HealthDay News) --,The time at ... affect their chances for survival, new research suggests. ... weekends or during holidays is associated with a 13 ... business hours, researchers report. Every year, more than ... most severe type of heart attack, which is caused ...
(Date:7/29/2014)... July 29, 2014 (HealthDay News) -- Chlorine helps keep ... more likely to develop eye infections, doctors say. ... as well as blurry vision, said Dr. Sampson Davis, ... in New Jersey. It,s important to understand why ... washes away the outer film layer of the eye ...
(Date:7/29/2014)... 29, 2014 The Board of Governors of ... Hart LLP ’s Connie Akridge to serve as ... as President of the Foundation. Akridge served as President of ... a partner at Holland & Hart in Las Vegas, providing ... matters to insurance and healthcare clients for more than 25 ...
(Date:7/29/2014)... 2014 Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ... suffered serious liver injuries due to the acetaminophen ... a multidistrict litigation underway in U.S. District Court, ... According to an Order dated July 23rd, the ... bellwether case and discovery issues. Among other things, ...
(Date:7/29/2014)... Dennis Thompson HealthDay Reporter ... healthy diet and good sleep can protect the body against ... process at a cellular level, researchers report. A study ... linked to increased shortening of telomeres, the protective caps at ... "We found that over a one-year period, the more ...
Breaking Medicine News(10 mins):Health News:Heart Attack Patients Treated at Night, Weekends May Have Worse Outcomes 2Health News:Protect Your Eyes When Hitting the Pool 2Health News:Holland & Hart LLP Attorney Connie Akridge Reappointed Trustee of the Nevada Bar Foundation 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:Healthy Habits May Slow Cellular Signs of Aging, Study Finds 2Health News:Healthy Habits May Slow Cellular Signs of Aging, Study Finds 3
... As the United States moves toward the goal of ... from the Regenstrief Institute provides a framework for evaluating the ... as the health internet. The study, which appears ... American Medical Informatics Association , also reports on the initial ...
... ... resource deployment through enhanced territory alignment , ... (PRWEB) May 11, 2010 -- The TerrAlign Group, Inc. a ... the inaugural launch of Veeva System’s Veeva Web™ program. Inclusion in this program ...
... So often the rare informs the common. Penn researchers ... have shown that it may be related to epileptic and ... A team of researchers from the University of Pennsylvania School ... professor of Neurology and director of the Penn Epilepsy Center, ...
... Oklahoma, Massachusetts asked to pull back products , TUESDAY, ... E.coli-tainted lettuce expanded late Monday as another food company ... farm currently under investigation by the U.S. Food and ... , According to the Associated Press , California-based ...
... Only ... ... KWizCom, a leading provider of critical SharePoint components to over 3,000 organizations around the ... giant AT&T. KWizCom’s Mobile Extensions , a smart phone connector that permits intelligent, ...
... Canvas Provides Health ... On Mobile Devices. , , ... Herndon, VA (PRWEB) May 11, 2010 -- Canvas announced today it had released ... HITECH compliant mobile applications on the Canvas service. The Health Insurance Portability and ...
Cached Medicine News:Health News:Measuring success: Regenstrief helps assess value of investment in health info tech 2Health News:TerrAlign Selected to Join Veeva System's Veeva Web Program 2Health News:TerrAlign Selected to Join Veeva System's Veeva Web Program 3Health News:TerrAlign Selected to Join Veeva System's Veeva Web Program 4Health News:Rare disease in Amish children sheds light on common neurological disorders 2Health News:Tainted Lettuce Recall Expands 2Health News:Tainted Lettuce Recall Expands 3Health News:KWizCom's Mobile Extensions for SharePoint Receive AT&T Certified Solutions Status 2Health News:HIPAA HITECH Compliant Mobile Apps Available for Android, Blackberry and Windows Mobile Smartphones 2Health News:HIPAA HITECH Compliant Mobile Apps Available for Android, Blackberry and Windows Mobile Smartphones 3Health News:HIPAA HITECH Compliant Mobile Apps Available for Android, Blackberry and Windows Mobile Smartphones 4
... Spatula Tips That Mimic Corneal Curvature. Designed To ... Created With The IntraLase TMFS Laser System., ... Of The Forceps Are Designed To Facilitate Access ... Achieved, The Cross-Action Forceps Design Allows The Surgeon ...
... Allowing The Exact,Outer Diameter Measurement Of A ... ,Increments.,Easy And Quick To Use, With One-HandedOperation. ... Over A Cornea For Confirmation Of Exact ... ,Guaranteed For ...
... Safely And Easily Cut Foldable Lenses Through ... The Incision., ,Specially Designed To Cut And ... Lenses With Ease With One Instrument., ,Ideal ... Lenses Which Are Damaged, The Wrong Diopter ...
... Gauge Measures 360 Degrees & Can Be ... A Cornea. 7mm Inner Diameter & 14mm Outer ... Only Astigmatism Gauge That Can Be Set For ... Degree Around The Globe., ,Marks Single Or Paired ...
Medicine Products: